Leede Financial Has Negative Outlook of QIPT FY2025 Earnings

Quipt Home Medical Corp. (NASDAQ:QIPT) – Analysts at Leede Financial lowered their FY2025 earnings per share estimates for shares of Quipt Home Medical in a research report issued to clients and investors on Wednesday, December 18th. Leede Financial analyst D. Loe now forecasts that the company will post earnings per share of ($0.15) for the year, down from their previous estimate of ($0.03). The consensus estimate for Quipt Home Medical’s current full-year earnings is ($0.10) per share. Leede Financial also issued estimates for Quipt Home Medical’s FY2026 earnings at ($0.12) EPS.

Quipt Home Medical Price Performance

Shares of NASDAQ QIPT opened at $2.41 on Friday. The company has a quick ratio of 0.77, a current ratio of 1.11 and a debt-to-equity ratio of 0.66. Quipt Home Medical has a twelve month low of $2.30 and a twelve month high of $5.29. The business’s 50 day moving average price is $2.69 and its two-hundred day moving average price is $2.95. The company has a market cap of $103.85 million, a PE ratio of -21.91 and a beta of 0.62.

Quipt Home Medical (NASDAQ:QIPT) last announced its quarterly earnings data on Monday, December 16th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.08). Quipt Home Medical had a negative net margin of 1.95% and a negative return on equity of 4.51%.

Institutional Trading of Quipt Home Medical

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Forager Capital Management LLC lifted its position in shares of Quipt Home Medical by 77.7% during the 3rd quarter. Forager Capital Management LLC now owns 4,192,562 shares of the company’s stock valued at $12,200,000 after acquiring an additional 1,833,590 shares during the period. Royce & Associates LP lifted its holdings in shares of Quipt Home Medical by 15.8% during the 3rd quarter. Royce & Associates LP now owns 1,768,789 shares of the company’s stock worth $5,165,000 after acquiring an additional 240,980 shares during the period. Verition Fund Management LLC increased its stake in Quipt Home Medical by 207.5% in the third quarter. Verition Fund Management LLC now owns 78,950 shares of the company’s stock valued at $231,000 after acquiring an additional 53,275 shares during the last quarter. Rhumbline Advisers raised its position in Quipt Home Medical by 21.0% during the second quarter. Rhumbline Advisers now owns 49,276 shares of the company’s stock valued at $159,000 after purchasing an additional 8,541 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its stake in Quipt Home Medical by 32.8% during the second quarter. Bank of New York Mellon Corp now owns 129,738 shares of the company’s stock worth $418,000 after purchasing an additional 32,073 shares during the last quarter. Institutional investors own 42.85% of the company’s stock.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.